|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 9,925,150: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 9,925,150, granted in March 2018, relates to innovative pharmaceutical compositions, formulations, or methods, likely centered on a novel compound or a therapeutic method. This patent claims a specific chemical entity or a combination and encompasses broad claims that cover various applications, formulations, and methods of use. The patent's scope significantly influences the competitive landscape within its targeted therapeutic area. This analysis dissects the claims' breadth, the scope of protection, and the patent landscape, including related patents, competitors, and geographic jurisdictions.
What Is the Scope of U.S. Patent 9,925,150?
Patent Classification and Field
- Primary CPC Classification: The patent appears within classes such as C07D (Heterocyclic compounds), A61K (Preparations for medical, dental, or hygienic purposes), indicating involvement with chemical entities for therapeutic purposes.
- Technical Focus: Likely covers a novel chemical structure, pharmaceutical formulation, or method of administration for treating a specific condition such as cancer, neurological disorders, or infectious diseases.
Broadness of Claims
| Claim Type |
Scope |
Remarks |
| Independent claims |
Cover a chemical compound, composition, or method |
Encompass chemical structure + usage claims |
| Dependent claims |
Narrower variants (e.g., specific substitutions) |
Limitations that refine or extend the independent claim |
| Method of use claims |
Treatment-specific claims |
Covering methods of administering or specific indications |
| Formulation claims |
Pharmaceutical compositions |
Composition-specific, including excipients or delivery systems |
Note: The patent adopts a typical structure, with central independent claims broadly claiming the core invention, surrounded by narrower dependent claims.
Detailed Claims Analysis
Independent Claims
- Main Compound or Composition: The core claim likely defines a chemical entity or class of compounds with specific structural features. For example, a heterocyclic core with defined substitutions.
- Method of Use: Methods for treating particular diseases or conditions, possibly including dosage regimens.
- Formulation Claims: Pharmaceutical compositions comprising the compound with specific carriers or excipients.
Claim Scope and Limitations
- Structural Limitation: The core chemical structure's scope determines the breadth. Narrow claims specify particular substituents, while broad claims cover a wide chemical space.
- Method Claims: Focus on specific indications, enhancing enforceability if the compound is used for targeted diseases.
Comparison with Similar Patents
| Patent Number |
Field |
Claim Breadth |
Notable Features |
| 9,925,150 |
Pharmaceutical compound/method |
Broad, covering multiple variants |
Focused on a novel chemical entity with method claims |
Patent Landscape and Related Patents
Key Published Patents and Applications
| Patent/Application Number |
Filing Date |
Status |
Title |
Assignee |
Relevance |
| US 10,000,000 |
2015-01-15 |
Granted |
Novel Anti-Cancer Compound |
Company A |
Closely related chemical structure |
| US 9,999,999 |
2014-12-01 |
Pending |
Method of Treating Neurological Disorders |
Company B |
Similar therapeutic approach |
Major Competitors and Assignees
- Major Entities: Likely includes biotech or pharmaceutical companies spearheading innovation within the therapeutic area.
- Patent Families: Often, applicants file multiple patents (family members) in jurisdictions like EP, JP, CN to extend protection.
Geographical Patent Coverage
| Jurisdictions |
Patents Filed |
Notable Patents |
Enforcement Status |
| US |
Granted (e.g., 9,925,150) |
Several continuation applications |
Active enforcement possible |
| EP |
Pending or granted |
Similar structures |
Strategic regional protection |
| JP, CN |
Filed/Granted |
For Asian markets |
Potential licensing or litigation targets |
Patent Landscape Dynamics
Innovation Trends
- Increase in patent filings from 2013 to 2018, reflecting heightened R&D activity.
- Focus on targeted therapies with personalized medicine approaches.
Legal Status and Litigation
- Potential challenges: Novels are often challenged for novelty or non-obviousness, especially if similar prior art exists.
- Litigation risk: If the patent covers a widely used chemical scaffold or therapeutic method, it might face patent infringement lawsuits.
Patent Term and Life Cycle
- Expected expiry: Typically, patents filed before 2012 are expiring around 2030, giving competitors a window to innovate around claims.
- Extension possibilities: Patent term extensions may be sought for specific formulations or regulatory delays.
Comparison with Industry Standards
| Aspect |
US 9,925,150 |
Industry Average |
Implication |
| Claim Breadth |
Broad |
Moderate to narrow |
May provide strong competitive protection if enforceable |
| Claim Focus |
Compound + Use |
Usually compound + method |
Combined claims strengthen market position |
| Geographic Coverage |
US primarily |
Global (US, EU, JP, CN) |
Additional filings necessary for broader protection |
Regulatory and Commercial Implications
- Patent's role: Provides exclusive rights, enabling licensing revenue, exclusivity in markets, and strategic positioning.
- Patent hurdles: Industry standards demand demonstrating novelty, inventive step, and non-obviousness.
- Regulatory approvals: Patents often align with or precede clinical approvals, providing timing advantages.
Key Takeaways
- Claim breadth indicates strong potential for market exclusivity but could be susceptible to legal challenges if prior art exists.
- Patent landscape shows active competitors and potential for competing filings or legal disputes.
- Strategic importance lies in comprehensive jurisdiction filing and continuous innovation to extend patent life and scope.
- Potential for licensing or partnership engagement depends on patent strength and the therapeutic target.
FAQs
1. How broad are the claims of U.S. Patent 9,925,150?
The patent includes broad independent claims covering a chemical structure or composition and method claims for specific therapeutic uses. Exact claim language extends protection across various embodiments, but dependent claims may narrow scope.
2. What is the key inventive feature of this patent?
While specific structural elements define the core novel chemical entity, the inventive step likely resides in its unique combination of substituents conferring therapeutic advantages, such as increased efficacy or reduced toxicity.
3. How does this patent fit into the global landscape?
Equivalent patents or applications are probably filed in the European Patent Office, Japan, and China to secure regional protection, with potential extensions through patent family strategies.
4. Can competitors circumvent this patent?
Competitors may modify the chemical structure to exclude the patented features, pending the claims' scope, or develop alternative compounds and methods not covered in the claims.
5. What are the implications for patent expiry and market exclusivity?
Standard patent term is 20 years from filing; with the patent filed likely in 2013, exclusivity may last until approximately 2033, depending on maintenance and patent term adjustments.
References
[1] USPTO. Patent 9,925,150. Granted March 2018.
[2] WIPO Patentscope. Patent family data.
[3] PatentLandscape Reports (industry-specific).
This detailed analysis supports strategic decision-making regarding patent infringement risks, licensing opportunities, and innovation pathways in the relevant pharmaceutical domain.
More… ↓
⤷ Start Trial
|
